There were 15 clusters including first-line treatment, epidermal growth factor receptor (EGFR) expression, pyrotinib-based therapy, the prognostic index, and other clusters, demonstrating the development of research focus on breast cancer brain metastasis. This evidence concerns the gene EGFR and breast carcinoma.